<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02735200</url>
  </required_header>
  <id_info>
    <org_study_id>DammamU</org_study_id>
    <nct_id>NCT02735200</nct_id>
  </id_info>
  <brief_title>Topical Delivery of Vitamin D3 as Vitamin D Supplementation</brief_title>
  <official_title>Topical Delivery of Vitamin D3: A Randomized Controlled Trial (RCT)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dammam University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dammam University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      After obtaining the approval from the IRB of University of Dammam and informed consent from
      550 healthy patients, with vitamin D deficiency and vitamin D insufficiency and deficiency
      were recruited. Age, weight and height will be taken, a detailed history, meticulous clinical
      examination was performed to rule out any diseases and complete blood picture, serum calcium,
      phosphorous, alkaline phosphatase, Parathormone and 25 Hydroxy-vitamin D (25OHD) will be
      done. 25-Hydroxy Vitamin D3 was measured in house by chemiluminescence immunoassay (CLIA) and
      ≥30ng/mL was taken as normal, 21-29ng/mL as insufficiency and ≤20 ng/mL as deficiency. The
      participants were divided into two groups of 350 in study arm and 200 in control arm. All
      participants were instructed not to change their dietary habits and life style till the study
      was over. The study group of women were instructed to apply to apply Top-D (Proniosomal
      Delivered- Vitamin D3) 1 gram containing 5000 IU of vitamin D3. The second group used 1 gram
      of Aloe vera gel. The participants had no knowledge to which group they belong. A second
      blood sample was taken at the end of 4 months and the data was entered in the data base and
      analyzed using SPSS Inc version 19.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After obtaining the approval from the Institutional Review Board (IRB) of University of
      Dammam and informed consent from 550 healthy patients, with vitamin D deficiency and vitamin
      D insufficiency and deficiency were recruited. Age, weight and height will be taken, a
      detailed history, meticulous clinical examination was performed to rule out any diseases and
      complete blood picture, serum calcium, phosphorous, alkaline phosphatase, Parathormone and 25
      Hydroxy-vitamin D (25OHD) will be done. 25-Hydroxy Vitamin D3 was measured in house by
      chemiluminescence immunoassay (CLIA) and ≥30ng/mL was taken as normal, 21-29ng/mL as
      insufficiency and ≤20 ng/mL as deficiency. The participants were divided into two groups of
      350 in study arm and 200 in control arm. All participants were instructed not to change their
      dietary habits and life style till the study was over. The study group of women were
      instructed to apply to apply Top-D (Proniosomal Delivered- Vitamin D3) I gram gram containing
      5000 IU of vitamin D3. The second group used 1 gram of Aloe vera gel. The participants had no
      knowledge to which group they belong. A second blood sample was taken at the end of 4 months
      and the data was entered in the data base and analyzed using SPSS Inc version 19.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Actual">December 30, 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>assignment</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Level of Serum 25 OHD Level Pre-treatment and Post Treatment</measure>
    <time_frame>baseline and 5 months</time_frame>
    <description>Patients had analysis of serum 25 OHD level pre and post treatment, to check if treatment with Topical Vitamin D made any difference.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">550</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>Topical Vitamin D3 application</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention is Application of topical Vitamin D3 Frequency: Daily Dosage: 1 gram (5000 IU) Duration: 120 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aloe vera gel Application</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Application of Aloe vera gel will be carried out Dosage: 1 gram Frequency: Daily Duration: 120 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Application of topical vitamin d3 (Top-D)</intervention_name>
    <description>Topical Vitamin D3 will be applied on the skin, externally, 1 gram daily for 120 days</description>
    <arm_group_label>Topical Vitamin D3 application</arm_group_label>
    <other_name>Topical vitamin D3</other_name>
    <other_name>TOP-D</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Application of Aloe vera gel</intervention_name>
    <description>aloe vera gel will be applied
Dosage: 1 gram Duration: 120 days Frequency: Daily</description>
    <arm_group_label>Aloe vera gel Application</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        all men and women with vitamin D insufficiency and deficiency Must be able to apple the
        topical vitamin D3 Must be willing to sign and informed consent

        Exclusion Criteria:

          -  Those who have normal 25OHD levels
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Naif AlMasoud, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Dammam, Saudi Arabia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>King Fahd Hospital of the University</name>
      <address>
        <city>AlKhobar</city>
        <zip>31952</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Saudi Arabia</country>
  </location_countries>
  <reference>
    <citation>Riccio PA, Zingaretti C, Milani M, Ricci Petitoni G, Monti G, Pavanello PM. [Thymoma: diagnosis and surgical treatment]. Minerva Chir. 1996 Sep;51(9):663-7. Italian.</citation>
    <PMID>9082230</PMID>
  </reference>
  <reference>
    <citation>Sadat-Ali M, AlElq A, Al-Turki H, Al-Mulhim F, Al-Ali A. Vitamin D levels in healthy men in eastern Saudi Arabia. Ann Saudi Med. 2009 Sep-Oct;29(5):378-82.</citation>
    <PMID>19700896</PMID>
  </reference>
  <reference>
    <citation>Elsammak MY, Al-Wosaibi AA, Al-Howeish A, Alsaeed J. Vitamin d deficiency in Saudi Arabs. Horm Metab Res. 2010 May;42(5):364-8. doi: 10.1055/s-0030-1248296. Epub 2010 Mar 8.</citation>
    <PMID>20213587</PMID>
  </reference>
  <reference>
    <citation>Al-Elq AH. The status of Vitamin D in medical students in the preclerkship years of a Saudi medical school. J Family Community Med. 2012 May;19(2):100-4. doi: 10.4103/2230-8229.98293.</citation>
    <PMID>22870413</PMID>
  </reference>
  <reference>
    <citation>Grant AM, Avenell A, Campbell MK, McDonald AM, MacLennan GS, McPherson GC, Anderson FH, Cooper C, Francis RM, Donaldson C, Gillespie WJ, Robinson CM, Torgerson DJ, Wallace WA; RECORD Trial Group. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet. 2005 May 7-13;365(9471):1621-8.</citation>
    <PMID>15885294</PMID>
  </reference>
  <reference>
    <citation>Porthouse J, Cockayne S, King C, Saxon L, Steele E, Aspray T, Baverstock M, Birks Y, Dumville J, Francis R, Iglesias C, Puffer S, Sutcliffe A, Watt I, Torgerson DJ. Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ. 2005 Apr 30;330(7498):1003.</citation>
    <PMID>15860827</PMID>
  </reference>
  <reference>
    <citation>Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, Bassford T, Beresford SA, Black HR, Blanchette P, Bonds DE, Brunner RL, Brzyski RG, Caan B, Cauley JA, Chlebowski RT, Cummings SR, Granek I, Hays J, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Johnson KC, Judd H, Kotchen JM, Kuller LH, Langer RD, Lasser NL, Limacher MC, Ludlam S, Manson JE, Margolis KL, McGowan J, Ockene JK, O'Sullivan MJ, Phillips L, Prentice RL, Sarto GE, Stefanick ML, Van Horn L, Wactawski-Wende J, Whitlock E, Anderson GL, Assaf AR, Barad D; Women's Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med. 2006 Feb 16;354(7):669-83. Erratum in: N Engl J Med. 2006 Mar 9;354(10):1102.</citation>
    <PMID>16481635</PMID>
  </reference>
  <reference>
    <citation>Nikolaus T, Kruse W, Bach M, Specht-Leible N, Oster P, Schlierf G. Elderly patients' problems with medication. An in-hospital and follow-up study. Eur J Clin Pharmacol. 1996;49(4):255-9.</citation>
    <PMID>8857069</PMID>
  </reference>
  <reference>
    <citation>Thomas BJ, Finnin BC. The transdermal revolution. Drug Discov Today. 2004 Aug 15;9(16):697-703. Review.</citation>
    <PMID>15341783</PMID>
  </reference>
  <reference>
    <citation>Shi Y, Wei Z, Zhao H, Liu T, Dong A, Zhang J. Electrospinning of ibuprofen-loaded composite nanofibers for improving the performances of transdermal patches. J Nanosci Nanotechnol. 2013 Jun;13(6):3855-63.</citation>
    <PMID>23862418</PMID>
  </reference>
  <reference>
    <citation>Derry S, Moore RA. Topical capsaicin (low concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2012 Sep 12;(9):CD010111. doi: 10.1002/14651858.CD010111. Review.</citation>
    <PMID>22972149</PMID>
  </reference>
  <reference>
    <citation>Aggarwal N, Goindi S. Preparation and in vivo evaluation of solid lipid nanoparticles of griseofulvin for dermal use. J Biomed Nanotechnol. 2013 Apr;9(4):564-76.</citation>
    <PMID>23621015</PMID>
  </reference>
  <reference>
    <citation>Ahad A, Al-Jenoobi FI, Al-Mohizea AM, Aqil M, Kohli K. Transdermal delivery of calcium channel blockers for hypertension. Expert Opin Drug Deliv. 2013 Aug;10(8):1137-53. doi: 10.1517/17425247.2013.783562. Epub 2013 Mar 26. Review.</citation>
    <PMID>23527660</PMID>
  </reference>
  <reference>
    <citation>Goodman MP. Are all estrogens created equal? A review of oral vs. transdermal therapy. J Womens Health (Larchmt). 2012 Feb;21(2):161-9. doi: 10.1089/jwh.2011.2839. Epub 2011 Oct 19. Review.</citation>
    <PMID>22011208</PMID>
  </reference>
  <reference>
    <citation>Segal E, Zinman C, Raz B, Ish-Shalom S. Low patient compliance--a major negative factor in achieving vitamin D adequacy in elderly hip fracture patients supplemented with 800IU of vitamin D3 daily. Arch Gerontol Geriatr. 2009 Nov-Dec;49(3):364-7. doi: 10.1016/j.archger.2008.12.001. Epub 2009 Jan 14.</citation>
    <PMID>19147237</PMID>
  </reference>
  <reference>
    <citation>Castelo-Branco C, Cortés X, Ferrer M; UNICAD study investigators. Treatment persistence and compliance with a combination of calcium and vitamin D. Climacteric. 2010 Dec;13(6):578-84. doi: 10.3109/13697130903452804. Epub 2009 Dec 1.</citation>
    <PMID>19951084</PMID>
  </reference>
  <reference>
    <citation>Sanfelix-Genovés J, Gil-Guillén VF, Orozco-Beltran D, Giner-Ruiz V, Pertusa-Martínez S, Reig-Moya B, Carratalá C. Determinant factors of osteoporosis patients' reported therapeutic adherence to calcium and/or vitamin D supplements: a cross-sectional, observational study of postmenopausal women. Drugs Aging. 2009;26(10):861-9. doi: 10.2165/11317070-000000000-00000.</citation>
    <PMID>19761279</PMID>
  </reference>
  <results_reference>
    <citation>Sadat-Ali M, Bubshait DA, Al-Turki HA, Al-Dakheel DA, Al-Olayani WS. Topical delivery of vitamin d3: a randomized controlled pilot study. Int J Biomed Sci. 2014 Mar;10(1):21-4.</citation>
    <PMID>24711745</PMID>
  </results_reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 12, 2016</study_first_submitted>
  <study_first_submitted_qc>April 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 12, 2016</study_first_posted>
  <results_first_submitted>January 28, 2017</results_first_submitted>
  <results_first_submitted_qc>May 11, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">June 14, 2017</results_first_posted>
  <last_update_submitted>May 11, 2017</last_update_submitted>
  <last_update_submitted_qc>May 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Orthopedic clinics</recruitment_details>
      <pre_assignment_details>consecutive patients</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Application of Aloe Vera Gel</title>
          <description>Intervention: aloe vera gel administration was applied 1 gram daily for 120 days.</description>
        </group>
        <group group_id="P2">
          <title>Topical Application of Vitamin D3</title>
          <description>topical vitamin D3 in intervention group: local application of Top-D, 1 gram (5000 IU) was applied every day, for 120 days.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="200"/>
                <participants group_id="P2" count="350"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="192"/>
                <participants group_id="P2" count="345"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Topical Application of Vitamin D3</title>
          <description>this arm received topical vitamin D3 1gram (5000IU)</description>
        </group>
        <group group_id="B2">
          <title>Application of Aloe Vera Gel</title>
          <description>Intervention: aloe vera gel administration 1 gram</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="350"/>
            <count group_id="B2" value="200"/>
            <count group_id="B3" value="550"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="350"/>
                    <count group_id="B2" value="200"/>
                    <count group_id="B3" value="550"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="300"/>
                    <measurement group_id="B2" value="171"/>
                    <measurement group_id="B3" value="471"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="350"/>
                    <count group_id="B2" value="200"/>
                    <count group_id="B3" value="550"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42.59" spread="15.74"/>
                    <measurement group_id="B2" value="41.6" spread="16.6"/>
                    <measurement group_id="B3" value="41.9" spread="16.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="350"/>
                    <count group_id="B2" value="200"/>
                    <count group_id="B3" value="550"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="285"/>
                    <measurement group_id="B2" value="137"/>
                    <measurement group_id="B3" value="422"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="65"/>
                    <measurement group_id="B2" value="63"/>
                    <measurement group_id="B3" value="128"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Saudi Arabia</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="350"/>
                    <count group_id="B2" value="200"/>
                    <count group_id="B3" value="550"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="350"/>
                    <measurement group_id="B2" value="200"/>
                    <measurement group_id="B3" value="550"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Level of Serum 25 OHD Level Pre-treatment and Post Treatment</title>
        <description>Patients had analysis of serum 25 OHD level pre and post treatment, to check if treatment with Topical Vitamin D made any difference.</description>
        <time_frame>baseline and 5 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Topical Application of Vitamin D3</title>
            <description>Intervention: patients will be administered topical vitamin D3 5000 IU
topical vitamin D3 in intervention group: local application</description>
          </group>
          <group group_id="O2">
            <title>Application of Aloe Vera Gel</title>
            <description>Intervention: aloe vera gel administration</description>
          </group>
        </group_list>
        <measure>
          <title>Level of Serum 25 OHD Level Pre-treatment and Post Treatment</title>
          <description>Patients had analysis of serum 25 OHD level pre and post treatment, to check if treatment with Topical Vitamin D made any difference.</description>
          <units>ng/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="345"/>
                <count group_id="O2" value="192"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>pre treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.03" spread="4.57"/>
                    <measurement group_id="O2" value="10.36" spread="4.09"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>post treatment</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37.17" spread="6.04"/>
                    <measurement group_id="O2" value="10.51" spread="3.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.9</p_value>
            <p_value_desc>the p value correspond to the pretreatment time frame.</p_value_desc>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>1.67</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>p value corresponds to the post treatment time frame.</p_value_desc>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>26.66</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Topical Application of Vitamin D3</title>
          <description>Intervention: patients will be administered topical vitamin D3 5000 IU
topical vitamin D3 in intervention group: local application</description>
        </group>
        <group group_id="E2">
          <title>Application of Aloe Vera Gel</title>
          <description>Intervention: aloe vera gel administration
topical vitamin D3 in intervention group: local application</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="345"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="192"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="345"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="192"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="345"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="192"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>we did have a limitation of not performing the absorption studies, which could have strenthened the study robustly.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr Dalal Bubshait</name_or_title>
      <organization>Dammam University</organization>
      <phone>+966505848281</phone>
      <email>dbubshait@ud.edu.sa</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

